Proportion of isolates with resistance to azithromycin reported to in Netherlands
Netherlands: Proportion of isolates with resistance to azithromycin reported to was 14.8 in 2020. ◆ Volatile
Proportion of isolates with resistance to azithromycin reported to in Netherlands, 2009–2020
Source: World Health Organization, Global Health Observatory.
Analysis
In 2020, proportion of isolates with resistance to azithromycin reported to in Netherlands stood at 14.8. That is the highest value across all 11 years on record.
Compared with earlier readings it is up 38.3% on the previous year and up 253.6% over ten years.
Over the whole period, proportion of isolates with resistance to azithromycin reported to in Netherlands peaked at 14.8 in 2020 and was at its lowest, 0.6849, in 2012.
That places Netherlands 10th out of 47 countries with data for 2020, putting it in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Proportion of isolates with resistance to azithromycin reported to in Netherlands, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 2.63 | — |
| 2010 | 4.19 | +59.1% |
| 2011 | 5.53 | +32.1% |
| 2012 | 0.6849 | -87.6% |
| 2013 | 1.44 | +110.1% |
| 2014 | 1.76 | +22.5% |
| 2015 | 4 | +127.0% |
| 2016 | 1.96 | -51.0% |
| 2017 | 5.6 | +185.6% |
| 2018 | 10.7 | +91.1% |
| 2020 | 14.8 | +38.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.63 | 2.63 | 2.63 | 1 |
| 2010s | 3.98 | 0.6849 | 10.7 | 9 |
| 2020s | 14.8 | 14.8 | 14.8 | 1 |
Countries ranked near Netherlands
More health data for Netherlands
- Un projection of annual infant deaths, annual growth rate -2.44 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1866 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,235 deaths per 1,000 people (2090)
- Number of infants who die before age 1 80 deaths (2100)
- Population ages 60-64, female, annual growth rate 1.37 % change on previous year (2025)
- Population ages 60-64, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, female, per capita 0.0345 units per person (2025)
- Population ages 60-64, male, annual growth rate 1.43 % change on previous year (2025)
- Population ages 60-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, male, per capita 0.0341 units per person (2025)
Frequently asked questions
- What is proportion of isolates with resistance to azithromycin reported to in Netherlands?
- Proportion of isolates with resistance to azithromycin reported to in Netherlands was 14.8 in 2020, according to World Health Organization, Global Health Observatory.
- What is the highest proportion of isolates with resistance to azithromycin reported to recorded in Netherlands?
- The highest recorded value was 14.8 in 2020.
- What is the lowest proportion of isolates with resistance to azithromycin reported to recorded in Netherlands?
- The lowest recorded value was 0.6849 in 2012.
- How does Netherlands rank for proportion of isolates with resistance to azithromycin reported to?
- Netherlands ranks 10th out of 47 countries with data for 2020.
- Is proportion of isolates with resistance to azithromycin reported to rising or falling in Netherlands?
- Over the last ten years it is up 253.6%. The long-run trend across the full record is volatile.
- Where does this Netherlands data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with resistance to azithromycin reported to WHO-GASP. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 11 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).